Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  Oslo Bors  >  Photocure ASA    PHO   NO0010000045

PHOTOCURE ASA (PHO)
Mes dernières consult.
Most popular
  Report  
SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll newsofficial PublicationsSector newsTweets

Photocure ASA : Mandatory notification of trade

share with twitter share with LinkedIn share with facebook
share via e-mail
0
03/22/2013 | 11:02am CEST
Photocure ASA - Selling price of shares

Reference is made to the statement dated 15.03.2013. The payment has been determined based on a selling price of NOK 40.2584 per share.

After exercising options, Grete Hogstad holds 8 750 unexercised options in the Company, corresponding to 8 750 shares at the strike price of NOK 20.30. In addition she holds; 7
200 unexercised options, corresponding to 7 200 shares at the strike price of NOK 32.00;
23 400 unexercised options, corresponding to 23 400 shares at the strike price of NOK
44.00; and 17 250 unexercised options, corresponding to 17 250 shares at the strike price of NOK 50.75. After completion of the abovementioned transactions, the primary insider holds 10 500 shares in the Company.
After exercising options, Gry Stensrud holds 6 250 unexercised options in the Company, corresponding to 6 250 shares at the strike price of 20.30. In addition she holds; 19 050 unexercised options, corresponding to 19 050 shares at the strike price of NOK 44.00; and 22 500 unexercised options, corresponding to 22 500 shares at the strike price of NOK 50.75. After completion of the abovementioned transactions, the primary insider holds 6 shares in the Company.

For further information, please contact: Photocure

CFO Erik Dahl
Tel: +47 450 55 000, Email: [email protected]

distributed by
share with twitter share with LinkedIn share with facebook
share via e-mail
0
Latest news on PHOTOCURE ASA
04/16PHOTOCURE ASA : Annual accounts 2017
AQ
04/16PHOTOCURE ASA : Notice of the annual general meeting 9 May 2018
AQ
04/03PHOTOCURE : Blue Light Flexible Cystoscopy followed by tumor treatment with Lase..
AQ
03/20PHOTOCURE : Hexvix® featured at the 2018 Annual European Association of Urology ..
AQ
02/27PHOTOCURE ASA : Results for the fourth quarter of 2017
AQ
02/20PHOTOCURE ASA : Presentation of the fourth quarter and full year 2017 results
AQ
02/16PHOTOCURE : Announces U.S. FDA Approval of New Indications for Blue Light Cystos..
AQ
01/08PHOTOCURE : to present at investor meetings in San Francisco
AQ
2017PHOTOCURE ASA : Presentation at the DNB Nordic Healthcare Conference, Oslo
AQ
2017PHOTOCURE ASA : Landmark Blue Light Cystoscopy with Cysview study is published i..
AQ
More news
News from SeekingAlpha
02/27Photocure ASA 2017 Q4 - Results - Earnings Call Slides 
02/203 THINGS IN BIOTECH YOU SHOULD LEARN : February 19, 2018 
2017PhotoCure ASA (PHCUF) Presents At Carnegie Nordic Healthcare Day - Slideshow 
2017Photocure ASA 2017 Q2 - Results - Earnings Call Slides 
2017PhotoCure ASA (PHCUF) Updates on Bladder Cancer - Slideshow 
Financials ( NOK)
Sales 2018 191 M
EBIT 2018 -28,7 M
Net income 2018 -19,4 M
Finance 2018 97,3 M
Yield 2018 -
P/E ratio 2018 -
P/E ratio 2019 16,94
EV / Sales 2018 2,73x
EV / Sales 2019 1,77x
Capitalization 619 M
Chart PHOTOCURE ASA
Duration : Period :
Photocure ASA Technical Analysis Chart | PHO | NO0010000045 | 4-Traders
Technical analysis trends PHOTOCURE ASA
Short TermMid-TermLong Term
TrendsNeutralNeutralNeutral
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 1
Average target price 36,0  NOK
Spread / Average Target 24%
EPS Revisions
Managers
NameTitle
Kjetil Hestdal President, Chief Executive Officer & Media Contact
Jan Hendrik Egberts Chairman
Gry Stensrud VP-Technical Development & Operations
Erik Dahl Chief Financial Officer
Inger Ferner Heglund Vice President-Research & Development
Sector and Competitors
1st jan.Capitalization (M$)
PHOTOCURE ASA5.13%77
JOHNSON & JOHNSON-9.68%338 522
PFIZER2.32%220 455
NOVARTIS-8.69%202 567
ROCHE HOLDING LTD.-11.66%193 904
MERCK AND COMPANY5.97%161 967